Creative Planning Boosts Stock Position in iShares US Pharmaceuticals ETF (NYSEARCA:IHE)

Creative Planning boosted its holdings in iShares US Pharmaceuticals ETF (NYSEARCA:IHE) by 12.3% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,856 shares of the company’s stock after buying an additional 203 shares during the quarter. Creative Planning owned approximately 0.08% of iShares US Pharmaceuticals ETF worth $297,000 at the end of the most recent quarter.

Other large investors have also bought and sold shares of the company. IFP Advisors Inc increased its holdings in iShares US Pharmaceuticals ETF by 34.2% in the fourth quarter. IFP Advisors Inc now owns 294 shares of the company’s stock valued at $47,000 after buying an additional 75 shares in the last quarter. Advanced Asset Management Advisors Inc purchased a new position in iShares US Pharmaceuticals ETF in the fourth quarter valued at about $54,000. Usca Ria LLC purchased a new position in iShares US Pharmaceuticals ETF in the third quarter valued at about $127,000. Intl Fcstone Inc. purchased a new position in iShares US Pharmaceuticals ETF in the fourth quarter valued at about $218,000. Finally, Janney Montgomery Scott LLC purchased a new position in shares of iShares US Pharmaceuticals ETF during the 4th quarter worth approximately $241,000.

Shares of IHE opened at $161.01 on Friday. The firm has a 50 day simple moving average of $161.54 and a 200-day simple moving average of $149.10. iShares US Pharmaceuticals ETF has a 1-year low of $136.66 and a 1-year high of $165.70.

iShares US Pharmaceuticals ETF Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.

Featured Story: Learning About the VIX – Volatility Index

Want to see what other hedge funds are holding IHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares US Pharmaceuticals ETF (NYSEARCA:IHE).

Institutional Ownership by Quarter for iShares US Pharmaceuticals ETF (NYSEARCA:IHE)

Receive News & Ratings for iShares US Pharmaceuticals ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares US Pharmaceuticals ETF and related companies with MarketBeat.com's FREE daily email newsletter.